The Buck Institute for Research on Aging announces the appointment of Nathan Price, PhD, to Professor and Co-Director of the Center for Human Healthspan. Price specializes in systems biology, artificial intelligence, and bioengineering. He has published more than 200 scientific papers and is co-author, with Buck Chief Innovation Officer and Distinguished Professor Lee Hood, of “The Age of Scientific Wellness.” Price has been named one of 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine and is a member of the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine.
Credit: Buck Institute
The Buck Institute for Research on Aging announces the appointment of Nathan Price, PhD, to Professor and Co-Director of the Center for Human Healthspan. Price specializes in systems biology, artificial intelligence, and bioengineering. He has published more than 200 scientific papers and is co-author, with Buck Chief Innovation Officer and Distinguished Professor Lee Hood, of “The Age of Scientific Wellness.” Price has been named one of 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine and is a member of the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine.
Dr. Price is Chief Scientific Officer of the healthy aging company Thorne. Price was also a Professor and Associate Director at the Institute for Systems Biology, where he was co-director of the Hood-Price Lab for Systems Biomedicine, and an Affiliate Faculty at the University of Washington in bioengineering and computer science. He received his PhD in bioengineering from the University of California, San Diego.
“I am really excited to welcome Nathan to the Buck faculty,” says Buck President and CEO Eric Verdin, MD. “Nathan’s expertise and experience is a terrific addition as we expand our focus into the human biology arena”. Buck Distinguished Professor Lee Hood is delighted to reunite with his former lab partner. “Having Nathan here as co-director of the Center for Human Healthspan will significantly propel our efforts,” says Hood. “We have so many projects in the pipeline. I am delighted to have the opportunity to work with him again.”
“I’m thrilled to join the Buck at this time of unprecedented progress in the field of research on aging,” says Price. “The Buck’s focus on healthspan and the deep well of expertise of my new Buck colleagues in aging research were key factors in my decision to join them. With recent advancements in AI and systems biology, there is no limit to what we can accomplish together.”
About the Buck Institute for Research on Aging
At the Buck, we aim to end the threat of age-related diseases for this and future generations. We bring together the most capable and passionate scientists from a broad range of disciplines to study mechanisms of aging and to identify therapeutics that slow down aging. Our goal is to increase human health span, or the healthy years of life. Located just north of San Francisco, we are globally recognized as the pioneer and leader in efforts to target aging, the number one risk factor for serious diseases including Alzheimer’s, Parkinson’s, cancer, macular degeneration, heart disease, and diabetes. The Buck wants to help people live better longer. Our success will ultimately change healthcare. Learn more at:
